John R Lake

Summary

Publications

  1. ncbi The role of immunosuppression in recurrence of hepatitis C
    John R Lake
    Gastroenterology Division, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 9:S63-6. 2003
  2. ncbi Do we really need long-term hepatitis B hyperimmune globulin? What are the alternatives?
    John R Lake
    Gastroenterology Division, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 14:S23-6. 2008
  3. ncbi Hot-topic debate on kidney function: renal-sparing approaches are ineffective
    John R Lake
    Division of Gastroenterology and Hepatology, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 17:S50-3. 2011
  4. ncbi Hepatitis B prophylaxis post-liver transplant without maintenance hepatitis B immunoglobulin therapy
    Dilip S Nath
    Department of Surgery, University of Minnesota Medical School, Minneapolis, 55455, USA
    Clin Transplant 20:206-10. 2006
  5. ncbi The impact of MELD allocation on simultaneous liver-kidney transplantation
    Julie A Thompson
    Division of Gastroenterology and Hepatology, 420 Delaware Street SE MMC 36, Minneapolis, MN 55455, USA
    Curr Gastroenterol Rep 11:76-82. 2009
  6. ncbi Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis
    John R Lake
    Gastroenterology Division, University of Minnesota, Minneapolis, Minnesota, USA
    Am J Transplant 5:549-57. 2005
  7. ncbi Prevention of post-transplant cardiovascular disease--report and recommendations of an ad hoc group
    Andrew D Bostom
    Department of Surgery, University of Minnesota, MMC-328 Mayo, Minneapolis 55455, USA
    Am J Transplant 2:491-500. 2002
  8. ncbi Technique of split-liver transplant for two adult recipients
    Abhinav Humar
    Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 8:725-9. 2002
  9. ncbi Hepatitis B immune globulin for life versus limited use: I favor limited duration of therapy
    John R Lake
    Liver Transplantation Program, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 8:S90-1. 2002
  10. ncbi Split-liver transplants for two adult recipients: technique of preservation of the vena cava with the right lobe graft
    Abhinav Humar
    Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 10:153-5. 2004

Collaborators

Detail Information

Publications17

  1. ncbi The role of immunosuppression in recurrence of hepatitis C
    John R Lake
    Gastroenterology Division, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 9:S63-6. 2003
    ..3. Change in the degree of immunosuppression, rather than the absolute amount of immunosuppression, is bad for HCV-infected recipients. 4. Corticosteroid boluses are bad for HCV-infected recipients...
  2. ncbi Do we really need long-term hepatitis B hyperimmune globulin? What are the alternatives?
    John R Lake
    Gastroenterology Division, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 14:S23-6. 2008
    ..4. Effective prophylaxis against HBV re-infection can now be accomplished with combination nucleoside/nucleotide anti-virals...
  3. ncbi Hot-topic debate on kidney function: renal-sparing approaches are ineffective
    John R Lake
    Division of Gastroenterology and Hepatology, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 17:S50-3. 2011
    ..4. The use of CNIs in the early posttransplant period is currently essential. 5. Whether new agents will be able to provide effective immunosuppression as primary immunosuppressives remains to be proven...
  4. ncbi Hepatitis B prophylaxis post-liver transplant without maintenance hepatitis B immunoglobulin therapy
    Dilip S Nath
    Department of Surgery, University of Minnesota Medical School, Minneapolis, 55455, USA
    Clin Transplant 20:206-10. 2006
    ..CONCLUSION: Longer follow-up is needed, but this regimen may represent an alternative to chronic HBIG maintenance therapy...
  5. ncbi The impact of MELD allocation on simultaneous liver-kidney transplantation
    Julie A Thompson
    Division of Gastroenterology and Hepatology, 420 Delaware Street SE MMC 36, Minneapolis, MN 55455, USA
    Curr Gastroenterol Rep 11:76-82. 2009
    ..Finally, recommendations regarding who should receive SLK transplants are reviewed...
  6. ncbi Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis
    John R Lake
    Gastroenterology Division, University of Minnesota, Minneapolis, Minnesota, USA
    Am J Transplant 5:549-57. 2005
    ..There are clear differences in risk factors for poor outcomes based on underlying liver disease, particularly with regard to the impact of donor age...
  7. ncbi Prevention of post-transplant cardiovascular disease--report and recommendations of an ad hoc group
    Andrew D Bostom
    Department of Surgery, University of Minnesota, MMC-328 Mayo, Minneapolis 55455, USA
    Am J Transplant 2:491-500. 2002
  8. ncbi Technique of split-liver transplant for two adult recipients
    Abhinav Humar
    Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 8:725-9. 2002
  9. ncbi Hepatitis B immune globulin for life versus limited use: I favor limited duration of therapy
    John R Lake
    Liver Transplantation Program, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 8:S90-1. 2002
  10. ncbi Split-liver transplants for two adult recipients: technique of preservation of the vena cava with the right lobe graft
    Abhinav Humar
    Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 10:153-5. 2004
  11. ncbi Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C
    Russell H Wiesner
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Liver Transpl 11:750-9. 2005
    ..In conclusion, the addition of MMF at discharge to tacrolimus-based immunosuppression is associated with improved long-term outcomes after liver transplantation in patients with and without HCV...
  12. ncbi The challenging patient: HCV and alcoholic liver disease
    Michael R Lucey
    Department of Medicine, University of Wisconsin, School of Medicine and Public Health, Madison, WI, USA
    Liver Transpl 13:S87-8. 2007
  13. ncbi Immunosuppression and outcomes of patients transplanted for hepatitis C
    John R Lake
    J Hepatol 44:627-9. 2006
  14. ncbi Role of tacrolimus in the evolution of liver transplantation
    Ronald W Busuttil
    Division of Liver and Pancreas Transplant, Department of Surgery, UCLA School of Medicine, Los Angeles, CA, USA
    Transplantation 77:S44-51. 2004
    ..In the decade since tacrolimus was approved for use in the United States, it has become a widely used immunosuppressant in the field of liver transplantation...
  15. ncbi MELD--an imperfect, but thus far the best, solution to the problem of organ allocation
    John R Lake
    J Gastrointestin Liver Dis 17:5-7. 2008
  16. ncbi Liver transplantation for erythropoietic protoporphyria liver disease
    Brendan M McGuire
    Department of Medicine, University of Alabama at Birmingham, 1530 Third Avenue South, Birmingham, AL 35294 0005, USA
    Liver Transpl 11:1590-6. 2005
    ..In conclusion, the 5-year patient survival rate in patients transplanted for EPP liver disease is good, but the recurrence of EPP liver disease appears to diminish long term graft and patient survival...
  17. ncbi The survival impact of liver transplantation in the MELD era, and the future for organ allocation and distribution
    Robert S Brown
    Am J Transplant 5:203-4. 2005